<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01909180</url>
  </required_header>
  <id_info>
    <org_study_id>106-2011-GES-0003</org_study_id>
    <nct_id>NCT01909180</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation for General Electric (GE) CT System</brief_title>
  <official_title>Clinical Evaluation for GE CT System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An external evaluation to obtain clinical data to create sample clinical images.

      The data will also be used for product and technology development, marketing materials, and
      inclusion in publications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The image data were assessed using a Likert scale for image quality sufficient for diagnostic
      assessment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image Quality</measure>
    <time_frame>24 hours</time_frame>
    <description>Image quality assessment on a 5 point Likert Scale:
5= Diagnostic- Excellent Image Quality 4= Diagnostic- Good Image Quality 3= Diagnostic-Acceptable Image Quality 2= Sub-Optimal Diagnostic with limited additional clinical information
1= Non-Diagnostic</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>CT Scanners X Ray</condition>
  <arm_group>
    <arm_group_label>Cardiac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revolution CT Cardiac Imaging Scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Body/Extremity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revolution CT Body and/or Extremity Imaging Scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neuro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revolution CT Brain and Spinal Cord Imaging Scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Revolution CT Scanner</intervention_name>
    <description>These scans would be considered &quot;standard of care&quot; but, because the subjects are scanned on an uncleared device they are investigational.</description>
    <arm_group_label>Cardiac</arm_group_label>
    <arm_group_label>Body/Extremity</arm_group_label>
    <arm_group_label>Neuro</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who voluntarily signed the Informed Consent Form (ICF).

          -  Male subjects 18 years of age or older.

          -  Female subjects 18 years of age or older. Females between 18 and 60 years of age must
             be non-lactating and non-pregnant as confirmed by negative urine pregnancy test.,
             unless they had surgery resulting in sterilization or are post-menopausal according to
             the medical history.

        Exclusion Criteria:

          -  â€¢ Subjects previously enrolled in this Evaluation.

               -  Subjects who are not able or not willing to give written Informed Consent.

               -  For IV contrast-enhanced CT exams, anyone with known or suspected allergy to
                  iodinated contrast agents or a history of multiple allergies or asthma.

               -  For IV contrast-enhanced CT exams, per the institution's guidelines on risk
                  stratification and prophylaxis for Contrast Induced Neuropathy, subjects will be
                  pre-screened via medical history review by qualified medical personnel for
                  suspected renal function impairment and high risk subjects will undergo a serum
                  creatinine lab test. Any subject with proven renal insufficiency will be
                  excluded.

               -  Known pregnancy and nursing (lactating) females.

               -  Any subject with urgent medical condition requiring acute care.

               -  Any conditions that, in the opinion of the Investigator, would interfere with the
                  evaluation of the results or constitute a health hazard for the subject.

               -  Subjects who do not agree to allow GEHC personnel to be present during the scan.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Curry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist South Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baptist South Florida Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2013</study_first_submitted>
  <study_first_submitted_qc>July 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2013</study_first_posted>
  <results_first_submitted>March 12, 2015</results_first_submitted>
  <results_first_submitted_qc>March 22, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 22, 2016</results_first_posted>
  <last_update_submitted>March 22, 2016</last_update_submitted>
  <last_update_submitted_qc>March 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard of Care Scan</title>
          <description>This is a single arm clinical trial.
Standard of care scan
Investigational Scan</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard of Care Scan</title>
          <description>This is a single arm clinical trial.
Standard of care scan
Investigational Scan</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Image Quality</title>
        <description>Image quality assessment on a 5 point Likert Scale:
5= Diagnostic- Excellent Image Quality 4= Diagnostic- Good Image Quality 3= Diagnostic-Acceptable Image Quality 2= Sub-Optimal Diagnostic with limited additional clinical information
1= Non-Diagnostic</description>
        <time_frame>24 hours</time_frame>
        <population>All cases were sufficient and had acceptable, good or excellent image quality</population>
        <group_list>
          <group group_id="O1">
            <title>Cardiac</title>
            <description>Subjects who received a cardiac CT scan</description>
          </group>
          <group group_id="O2">
            <title>Body/ Extremity</title>
            <description>Subject receiving a Revolution CT scan of the body or extremities</description>
          </group>
          <group group_id="O3">
            <title>Neuro</title>
            <description>Subjects receiving Revolution CT Scans of Brain or Spinal Cord</description>
          </group>
        </group_list>
        <measure>
          <title>Image Quality</title>
          <description>Image quality assessment on a 5 point Likert Scale:
5= Diagnostic- Excellent Image Quality 4= Diagnostic- Good Image Quality 3= Diagnostic-Acceptable Image Quality 2= Sub-Optimal Diagnostic with limited additional clinical information
1= Non-Diagnostic</description>
          <population>All cases were sufficient and had acceptable, good or excellent image quality</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Scan Images</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.53" spread="0.68"/>
                    <measurement group_id="O2" value="4.44" spread="0.67"/>
                    <measurement group_id="O3" value="4.63" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Standard of Care Scan</title>
          <description>This is a single arm clinical trial.
Standard of care scan
Investigational Scan</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Vomitting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>RIchard Petrisko</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>262-548-4637</phone>
      <email>richard.petrisko@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

